vaayaa Inclusive Education
Healthcare risk assessment

Gynecology and Reproductive Medicine Risk Assessment: Clinical Safety, Records and Continuity Controls

A worked example of how a gynecology and reproductive medicine service finds, scores and controls risks to patient safety, confidential records, specialist staffing, supplies and continuity of care.

Updated November 2026 8 hazards assessed Review every 6 months Highest risk: Critical to Medium
See the Gynecology and Reproductive Medicine course

Executive summary

This assessment shows how a gynecology and reproductive medicine service can identify, rate and control the risks that matter most to patient safety, privacy and continuity of care. Eight hazards were selected because they are plausible in outpatient clinics, procedure rooms and fertility services. Missed or delayed diagnosis, procedure complications and breaches of confidential records carry the highest inherent scores. Each hazard is scored before controls and again after existing and additional controls. Most fall to Medium or Low once controls are in place, but diagnostic delay, procedure complications and consent disputes stay at Medium because patient harm remains serious. The first actions are a tracked results pathway, a procedure readiness checklist, role based record access and a cross training plan for critical roles. This is a teaching example, so the scores illustrate method and do not describe any real service. Clinical decisions remain with licensed clinicians, and specialist review is needed for any real service.

Focus area
Gynecology and reproductive medicine
Setting
Outpatient and hospital gynecology, minor procedure, surgical and fertility monitoring services
Method
Five by five clinical likelihood and impact risk register

Scope

This assessment covers outpatient gynecology, minor procedures, surgical care and reproductive medicine services, including fertility consultations and monitoring, from referral and assessment through treatment, follow up and records. It looks at risks to patient safety, confidential data, staff capability, supplies and continuity. It does not give clinical guidance or cover any individual patient. Jurisdiction, funding model, service size and record system are not specified and are treated as assumptions for teaching.

Context

The example service has consultant gynecologists, specialist nurses, a sonographer, a partner fertility laboratory, theater staff and administrative teams. Patients are referred from primary care and attend clinics, day procedure units and imaging. Records are held in an electronic clinical system, and results arrive through laboratory interfaces. Each hazard is scored before controls to show its natural level, then again after existing controls and the additional controls that should be added. Owners are job roles, not named people, and the clinical governance lead reviews the register each cycle.

Objectives, assets and stakeholders

The objective is to deliver safe, timely and respectful care, protect confidential reproductive health information, keep fertility and surgical services running, and meet professional and regulatory duties in the relevant jurisdiction. Assets in scope include patient records, results and images, procedure rooms and equipment, medicines and consumables, specialist staff time, and laboratory samples and stored materials. Stakeholders include patients and their families, clinicians, nurses, theater and laboratory staff, administrators, referring doctors, suppliers, regulators and the board. Each risk has one owner role, and the clinical governance lead reports the register to the board each quarter. Patient wellbeing comes before service efficiency in every decision.

Risk matrix: before and after controls

Each cell shows hazard numbers placed by likelihood and impact. Compare the two grids to see how controls move each hazard.

Before controls

Inherent risk

Risk before controls: rows are likelihood from almost certain to rare, columns are impact from insignificant to catastrophic. Cells list hazard numbers.
1
Insignificant
2
Minor
3
Moderate
4
Major
5
Catastrophic
5 Almost certain
4 Likely Likelihood 4, impact 3, score 12, high: H05 Likelihood 4, impact 4, score 16, high: H01 Likelihood 4, impact 5, score 20, critical: H04
3 Possible Likelihood 3, impact 3, score 9, medium: H06 Likelihood 3, impact 4, score 12, high: H03 Likelihood 3, impact 5, score 15, high: H02 H07
2 Unlikely Likelihood 2, impact 3, score 6, medium: H08
1 Rare

After controls

Residual risk

Risk after controls: rows are likelihood from almost certain to rare, columns are impact from insignificant to catastrophic. Cells list hazard numbers.
1
Insignificant
2
Minor
3
Moderate
4
Major
5
Catastrophic
5 Almost certain
4 Likely
3 Possible Likelihood 3, impact 2, score 6, medium: H05
2 Unlikely Likelihood 2, impact 2, score 4, low: H06 H08 Likelihood 2, impact 3, score 6, medium: H03 Likelihood 2, impact 4, score 8, medium: H01 H02 H04 H07
1 Rare
  • Low 1 to 4
  • Medium 5 to 9
  • High 10 to 16
  • Critical 17 to 25

Hazard register

A summary first, then the detail for each hazard.

Summary of hazards with scores before and after controls
No.HazardBeforeAfterOwner
H01 Delayed or missed diagnosis from abnormal results or screening 16 High 8 Medium Clinical governance lead
H02 Procedure complication during gynecologic surgery or clinic procedure 15 High 8 Medium Theater services manager
H03 Prescribing or dosing error with hormonal and fertility medicines 12 High 6 Medium Lead pharmacist
H04 Breach of confidential reproductive health records 20 Critical 8 Medium Information governance lead
H05 Shortage of specialist staff and theater capacity 12 High 6 Medium Workforce and rota manager
H06 Single supplier dependence for devices, consumables or fertility medicines 9 Medium 4 Low Procurement manager
H07 Consent and ethical disputes in fertility and sterilization decisions 15 High 8 Medium Clinical ethics lead
H08 Reputational harm from complaints and poor communication 6 Medium 4 Low Patient experience lead
H01

Delayed or missed diagnosis from abnormal results or screening

Safety Before 16 After 8

Abnormal cytology, imaging or blood results are not reviewed, acted on or communicated to the patient in time, so a serious gynecologic condition is found later than it should be.

Who or what is affected: Patients, clinicians and referring doctors

Causes

Heavy inbox volume, results sent to someone who has left, and no tracking of patient contact.

Consequences

Late cancer diagnosis, poorer outcomes, complaints and legal claims.

Existing controls

  • Results are sent to the responsible clinician's inbox.
  • Abnormal cytology is reviewed at a weekly multidisciplinary meeting.

Control gaps

Results are routed to individuals rather than a team, so cover during leave is unreliable.

Additional controls

  • Prevent: Use a tracked results pathway with a named clinician and a maximum review time for each abnormal result.
  • Detect: Run a weekly report of results unreviewed after the agreed time and escalate them.
Likelihood 4 x impact 4 before; 2 x 4 after Owner: Clinical governance lead Target: Within 30 days Early warning: Abnormal results older than the agreed review time with no documented action.
H02

Procedure complication during gynecologic surgery or clinic procedure

Safety Before 15 After 8

Haemorrhage, organ injury, anesthetic reaction or infection occurs during an operation or office procedure because the checklist, equipment or team readiness is not adequate.

Who or what is affected: Patients, theater staff and surgeons

Causes

Complex cases, fatigue on long lists and equipment that is not checked before use.

Consequences

Harm to patients, emergency transfer, extended stays and claims.

Existing controls

  • A surgical safety checklist is used for every operation.
  • Consent forms list the main procedure risks.

Control gaps

Drills are run for some teams only, and equipment checks are not recorded.

Additional controls

  • Prevent: Confirm equipment, blood product availability and patient risk factors before each list starts.
  • Respond: Run a practiced emergency escalation drill for bleeding and anesthetic emergencies each quarter.
Likelihood 3 x impact 5 before; 2 x 4 after Owner: Theater services manager Target: Within 45 days Early warning: Unplanned return to theater or transfer within 48 hours of a procedure.
H03

Prescribing or dosing error with hormonal and fertility medicines

Safety Before 12 After 6

A wrong dose, wrong drug, missed allergy or wrong timing of a hormone or fertility medicine is prescribed or given, causing harm or a failed treatment cycle.

Who or what is affected: Patients, prescribers and pharmacy staff

Causes

Complex multi drug regimens, look alike packaging and changes between clinics.

Consequences

Adverse drug effects, cancelled cycles, harm and complaints.

Existing controls

  • Electronic prescribing checks for basic allergy alerts.
  • Fertility protocols are written and reviewed by the team.

Control gaps

Protocol versions are kept in different places, and sampling is rare.

Additional controls

  • Prevent: Use standard protocols with built in dose checks and pharmacist review for fertility regimens.
  • Detect: Audit a monthly sample of prescriptions against the protocol and record each variance.
Likelihood 3 x impact 4 before; 2 x 3 after Owner: Lead pharmacist Target: Within 60 days Early warning: Prescribing variance found in more than two audit samples in one month.
H04

Breach of confidential reproductive health records

Technology and data Before 20 After 8

Records, images or messages about pregnancy, fertility, sexual health or abnormal results are accessed without need, sent to the wrong person, or exposed through weak access control or phishing.

Who or what is affected: Patients, families and staff

Causes

Shared workstations, results emailed to wrong addresses and phishing that captures passwords.

Consequences

Harm to patients' privacy and safety, regulatory investigation and loss of trust.

Existing controls

  • Staff sign in with individual accounts.
  • Access to sensitive notes is logged.

Control gaps

Access logs are kept but rarely reviewed, and some messages are sent without encryption.

Additional controls

  • Prevent: Apply role based access so only the care team can open sensitive reproductive records, and enable multi factor sign in.
  • Detect: Review access logs each month and flag access to records unrelated to a current appointment.
Likelihood 4 x impact 5 before; 2 x 4 after Owner: Information governance lead Target: Within 30 days Early warning: Repeated failed sign ins or access to a record outside the care team.
H05

Shortage of specialist staff and theater capacity

People Before 12 After 6

Sickness, vacancies or training gaps leave clinics, theater or fertility monitoring short of a consultant, nurse, sonographer or embryologist, so care is delayed or cancelled.

Who or what is affected: Patients, staff and the service

Causes

Vacancies, high sickness and slow specialist training pipelines.

Consequences

Delayed care, cancelled procedures, staff burnout and unsafe working.

Existing controls

  • A duty rota is published four weeks ahead.
  • Bank staff are used for short notice gaps.

Control gaps

Backup staff are not kept current in their competence records.

Additional controls

  • Prevent: Cross train two staff for each critical role and keep a list of competent backup staff.
  • Respond: Triage cancellations by clinical priority and rebook urgent cases first.
Likelihood 4 x impact 3 before; 3 x 2 after Owner: Workforce and rota manager Target: Within 90 days Early warning: Sessions cancelled or staffed below the minimum in two consecutive weeks.
H06

Single supplier dependence for devices, consumables or fertility medicines

Supplier Before 9 After 4

A key device, consumable or fertility medicine comes from one supplier that fails, runs out or changes specification, so procedures and monitoring stop.

Who or what is affected: Patients, clinical teams and procurement

Causes

Single source contracts, supply shortages and short shelf life.

Consequences

Cancelled cycles, delayed procedures and extra cost.

Existing controls

  • Stock levels are checked each week.
  • The supplier contract includes a delivery service level.

Control gaps

Substitution plans are not tested against the clinical protocols.

Additional controls

  • Prevent: Qualify a second supplier for the most used consumables and agree a stock minimum.
  • Recover: Keep a documented substitution plan, approved by clinicians, for each critical item.
Likelihood 3 x impact 3 before; 2 x 2 after Owner: Procurement manager Target: Within 90 days Early warning: Stock below minimum for any critical item, or a late supplier delivery twice in one month.
H07

Consent and ethical disputes in fertility and sterilization decisions

Legal and compliance Before 15 After 8

Consent is unclear, incomplete or not refreshed before fertility treatment, storage of embryos or gametes, or a permanent contraceptive procedure, so the patient does not fully understand the choices or agreed decisions are disputed.

Who or what is affected: Patients, partners, clinicians and the ethics committee

Causes

Complex decisions, changing relationships and consent forms that are not revisited.

Consequences

Legal claims, distress to patients, breach of professional duties and reputational harm.

Existing controls

  • Written consent is taken before each fertility stage.
  • An ethics review process exists for unusual cases.

Control gaps

Consent for stored materials is not revisited on a fixed schedule.

Additional controls

  • Prevent: Use a standard consent checklist for storage, disposal and use decisions, refreshed when circumstances change.
  • Respond: Pause the treatment step and refer to the ethics lead when consent is disputed or unclear.
Likelihood 3 x impact 5 before; 2 x 4 after Owner: Clinical ethics lead Target: Within 60 days Early warning: Consent forms older than the agreed refresh period for ongoing storage.
H08

Reputational harm from complaints and poor communication

Reputational Before 6 After 4

Patients feel unheard after delayed results, poor explanations or discourteous conduct, and complaints or online reviews damage trust in the service.

Who or what is affected: Patients, staff and the service's standing

Causes

Long waits, unclear communication and limited staff time for explanation.

Consequences

Lost trust, fewer referrals, formal complaints and staff stress.

Existing controls

  • A complaints procedure is published.
  • Patient feedback is collected after each clinic.

Control gaps

Themes from patient feedback are not compared across clinics.

Additional controls

  • Respond: Acknowledge each complaint within the agreed time and offer a meeting with the clinical lead.
  • Detect: Review complaint themes monthly and act on any repeated concern.
Likelihood 2 x impact 3 before; 2 x 2 after Owner: Patient experience lead Target: Within 60 days Early warning: Repeated complaints on the same topic within one quarter.

Rating method and evaluation

Each risk is rated on two five-point scales. Likelihood runs from Rare to Almost certain, and impact runs from Minimal to Catastrophic, with harm to patients scored at the top of the impact scale. Multiplying the two gives a score from 1 to 25, which falls into one of four bands: Low from 1 to 4, Medium from 5 to 9, High from 10 to 16 and Critical from 17 to 25. Critical risks need immediate senior attention and a safeguard before the activity continues. High risks need a dated plan approved by the clinical governance lead, Medium risks need routine controls with a named owner, and Low risks are accepted and watched. Inherent risk is the score before any controls. Residual risk is the score after existing and additional controls are in place, and it can never be higher than the inherent score. Ratings are challenged by the clinicians who do the work, by a patient safety representative and by the risk owner in a short review, and any rating is revisited when an indicator reaches its threshold. Scores guide the ordering of work and are not a measurement of harm.

Likelihood, impact and rating bands

Likelihood

  • 5 Almost certain: Expected to happen in most circumstances.
  • 4 Likely: Will probably happen in many circumstances.
  • 3 Possible: Could happen at some time.
  • 2 Unlikely: Not expected, but it could happen.
  • 1 Rare: Only in exceptional circumstances.

Impact

  • 1 Insignificant: No lasting effect. Handled within routine work.
  • 2 Minor: Small effect that is quickly corrected.
  • 3 Moderate: Noticeable effect that needs managed effort to correct.
  • 4 Major: Serious effect on people, delivery or reputation.
  • 5 Catastrophic: Severe or lasting effect that threatens the whole activity.

Bands (likelihood x impact)

  • Low (1 to 4): Accept and monitor.
  • Medium (5 to 9): Manage with routine controls.
  • High (10 to 16): Senior attention and a treatment plan.
  • Critical (17 to 25): Act first. Do not proceed until reduced.

Monitoring, escalation and review

Review this assessment every 6 months, and sooner when an indicator below reaches its threshold.

Early-warning indicators and escalation thresholds
Indicator to watchEscalate when
Abnormal results past the agreed review time with no documented action.Escalate to the clinical governance lead at once when any result is overdue, and to the medical director after one week.
Unplanned returns to theater or transfers within 48 hours of a procedure.Escalate to the theater services manager within 24 hours and to the clinical governance lead for review.
Access to sensitive records outside the care team, found in monthly logs.Escalate to the information governance lead at once, with the data protection officer informed the same day.
Clinic or theater sessions cancelled or staffed below minimum for two weeks.Escalate to the workforce and rota manager and the operations director when two sessions in a row are affected.
Critical stock below minimum, or two late supplier deliveries in one month.Escalate to the procurement manager and the lead clinician for the affected service within 48 hours.

Contingency arrangements

If a serious event occurs, such as a missed critical result, a procedure complication or a confirmed breach of records, the clinical lead pauses the affected activity, ensures the patient receives urgent review and informs the patient openly. The information governance lead preserves the audit trail and contains the breach. Staff cover is drawn from the rota backup list so that clinics and theater can be safely reduced or stopped. Escalation to regulators or professional bodies is made through the medical director as required in the relevant jurisdiction. Fertility cycles and stored materials are protected by a documented continuity plan agreed with the partner laboratory.

Prioritized action plan

  1. Start the tracked results pathway with named clinicians and review times, owner clinical governance lead, within 30 days.
  2. Set role based record access and enable multi factor sign in, owner information governance lead, within 30 days.
  3. Introduce a procedure readiness checklist and drill bleeding emergencies, owner theater services manager, within 45 days.
  4. Qualify a second supplier for key consumables and approve substitution plans, owner procurement manager, within 90 days.
  5. Publish a cross training matrix and a backup staff list, owner workforce and rota manager, within 90 days.

Conclusion

Safe gynecology and reproductive care rests on a few steady habits: tracked results, checked procedures, role based access to records, backup staffing and clear consent. The highest scores sit with diagnostic delay, procedure complications, confidentiality and consent, and each has actions that bring the residual score down. Treat the register as a living record, review it on the stated cycle and after any incident, and seek qualified clinical, legal and data protection advice for any real decision.

Assumptions and limitations

Assumptions

  • Jurisdiction, funding model and regulators are not specified, so legal duties are described in general terms only.
  • The service has consultant gynecologists, specialist nurses, a sonographer and a partner fertility laboratory.
  • An electronic clinical record holds results and images, and staff use individual sign in on managed devices.

Limitations

  • The scores are examples for learning and do not describe any real service or patient group.
  • Clinical protocols change over time, so specialist clinical review is needed before any control is adopted.
  • This is educational content and does not replace a formal site-specific risk assessment or licensed clinical or legal advice.

Related frameworks to study

  • Clinical risk management cycle of identify, assess, control and review
  • Three lines model of risk ownership
  • Hierarchy of controls
  • Root cause analysis for incidents
  • Plan, do, check, act cycle for continual improvement

Healthcare Risk Assessment

China, India, United States, Indonesia, Pakistan, Nigeria, Brazil, Bangladesh, Russia, Japan, Mexico, Philippines, Vietnam, Egypt, Turkey, Germany, United Kingdom, France, Italy, Canada, South Korea, Australia, Spain.

For Learning Reference Only: This assessment demonstrates how risk assessment principles are applied in a practical setting, providing a useful reference for learning and understanding. Actual assessments may be adapted to suit specific site conditions and circumstances.

Keep learning

Study the subject behind this assessment.

More Healthcare risk assessments

Hourly Active: 39,499 Learners